AKT1 and breast carcinoma: In summary, our results indicate that the PI-3K pathway may play a more important role in mediating receptor tyrosine kinase-mediated resistance to chemotherapy and suggest that PI-3K/Akt might be a critical target molecule for anticancer intervention in breast cancer.